Colcrys
Product Images NDC 64764-119

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colcrys (NDC 64764-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Colcrys 01

Chemical structure of the active ingredient in Colcrys, showing the arrangement of atoms and bonds including methoxy groups and a lactone ring, consistent with the compound colchicine.*

FDA Label Image

Colcrys 02

A line graph comparing percentage improvement in patients treated with Colcrys at low-dose (1.8 mg), Colcrys at high-dose (4.8 mg), and placebo. The X-axis shows percentage improvement, while the Y-axis shows the percentage of patients improved. The graph shows Colcrys low-dose generally results in higher patient improvement than high-dose and placebo across the improvement percentages.*

FDA Label Image

Colcrys 03

Colcrys (colchicine USP) tablets 0.6 mg label from Takeda Pharmaceuticals America, Inc. The label indicates a package size of 30 tablets, NDC 64764-119-07, with storage instructions at 20°C to 25°C (68°F to 77°F). It includes directions to dispense in a tight, light-resistant container and a note for pharmacists to dispense with the medication guide attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.